Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298001611> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4298001611 abstract "Background: Uniformity and compliance with clinical practice guidelines (CPGs) for use of palivizumab in preventing severe RSV infection in Australian high-risk infants remain unclear. Methods: An online survey was conducted across the Australian and New Zealand Neonatal Network (ANZNN) to determine clinical practices around palivizumab. A literature search was also performed to identify and compare national and international guidelines. Results: Sixty-five of 422 ANZNN members completed the survey. Respondents included 61 senior medical staff of consultants/staff specialists (78%) and four nursing staff (6%). Infants most likely to be recommended palivizumab included preterm infants born <29 weeks gestational age (GA) (30%), children with chronic lung diseases (CLD) born <32 weeks GA (40%), and with hemodynamically significant heart disease (35%). Many respondents (53%) stated that CPGs for palivizumab were developed locally. Twenty guidelines (10 international and 10 domestic) were obtained in total; 16(80%) recommended palivizumab use in preterm infants, 16(80%) recommended use in infants with CLD, 17(85%) congenital heart disease (CHD) and six (30%) bronchopulmonary dysplasia (BPD). Eight (40%) guidelines provided specific recommendations for immunocompromised infants. Canada, Western Australia, and American Academy of Paediatrics provided recommendations for Indigenous children. Frequency and dosage of palivizumab was universal across all CPGs. None of the international guidelines obtained were from low- or middle-income countries. Conclusions: Standardisation of CPGs may improve clinical decision making around use of palivizumab in high-risk infants." @default.
- W4298001611 created "2022-10-01" @default.
- W4298001611 creator A5019487381 @default.
- W4298001611 creator A5025504700 @default.
- W4298001611 creator A5029364218 @default.
- W4298001611 creator A5036096862 @default.
- W4298001611 creator A5041358464 @default.
- W4298001611 creator A5053612434 @default.
- W4298001611 creator A5064665440 @default.
- W4298001611 date "2022-09-29" @default.
- W4298001611 modified "2023-10-11" @default.
- W4298001611 title "Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants" @default.
- W4298001611 doi "https://doi.org/10.22541/au.166419726.62754781/v2" @default.
- W4298001611 hasPublicationYear "2022" @default.
- W4298001611 type Work @default.
- W4298001611 citedByCount "0" @default.
- W4298001611 crossrefType "posted-content" @default.
- W4298001611 hasAuthorship W4298001611A5019487381 @default.
- W4298001611 hasAuthorship W4298001611A5025504700 @default.
- W4298001611 hasAuthorship W4298001611A5029364218 @default.
- W4298001611 hasAuthorship W4298001611A5036096862 @default.
- W4298001611 hasAuthorship W4298001611A5041358464 @default.
- W4298001611 hasAuthorship W4298001611A5053612434 @default.
- W4298001611 hasAuthorship W4298001611A5064665440 @default.
- W4298001611 hasBestOaLocation W42980016111 @default.
- W4298001611 hasConcept C126322002 @default.
- W4298001611 hasConcept C177713679 @default.
- W4298001611 hasConcept C187212893 @default.
- W4298001611 hasConcept C2778376644 @default.
- W4298001611 hasConcept C2778644256 @default.
- W4298001611 hasConcept C2778721537 @default.
- W4298001611 hasConcept C2779134260 @default.
- W4298001611 hasConcept C2779234561 @default.
- W4298001611 hasConcept C2780074459 @default.
- W4298001611 hasConcept C534529494 @default.
- W4298001611 hasConcept C54355233 @default.
- W4298001611 hasConcept C71924100 @default.
- W4298001611 hasConcept C86803240 @default.
- W4298001611 hasConceptScore W4298001611C126322002 @default.
- W4298001611 hasConceptScore W4298001611C177713679 @default.
- W4298001611 hasConceptScore W4298001611C187212893 @default.
- W4298001611 hasConceptScore W4298001611C2778376644 @default.
- W4298001611 hasConceptScore W4298001611C2778644256 @default.
- W4298001611 hasConceptScore W4298001611C2778721537 @default.
- W4298001611 hasConceptScore W4298001611C2779134260 @default.
- W4298001611 hasConceptScore W4298001611C2779234561 @default.
- W4298001611 hasConceptScore W4298001611C2780074459 @default.
- W4298001611 hasConceptScore W4298001611C534529494 @default.
- W4298001611 hasConceptScore W4298001611C54355233 @default.
- W4298001611 hasConceptScore W4298001611C71924100 @default.
- W4298001611 hasConceptScore W4298001611C86803240 @default.
- W4298001611 hasLocation W42980016111 @default.
- W4298001611 hasLocation W42980016112 @default.
- W4298001611 hasOpenAccess W4298001611 @default.
- W4298001611 hasPrimaryLocation W42980016111 @default.
- W4298001611 hasRelatedWork W1589200039 @default.
- W4298001611 hasRelatedWork W187419195 @default.
- W4298001611 hasRelatedWork W1965290079 @default.
- W4298001611 hasRelatedWork W2001093521 @default.
- W4298001611 hasRelatedWork W2223258418 @default.
- W4298001611 hasRelatedWork W2406276583 @default.
- W4298001611 hasRelatedWork W2406407808 @default.
- W4298001611 hasRelatedWork W2412634366 @default.
- W4298001611 hasRelatedWork W3092801021 @default.
- W4298001611 hasRelatedWork W3151680127 @default.
- W4298001611 isParatext "false" @default.
- W4298001611 isRetracted "false" @default.
- W4298001611 workType "article" @default.